Leukaemia and cancer in relation to immunosuppressive therapy.
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000328:Adult; D000361:Agammaglobulinemia / Q000188:drug therapy; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002869:Chromosome Aberrations; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016030:Kidney Transplantation; D007938:Leukemia / Q000139:chemically induced*; D004915:Leukemia, Erythroblastic, Acute / Q000139:chemically induced; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D007951:Leukemia, Myeloid / Q000139:chemically induced; D008223:Lymphoma / Q000139:chemically induced; D016403:Lymphoma, Large B-Cell, Diffuse / Q000139:chemically induced; D008228:Lymphoma, Non-Hodgkin / Q000139:chemically induced; D009366:Neoplasm Seeding; D009369:Neoplasms / Q000139:chemically induced*; D014019:Tissue Donors; D014184:Transplantation, Homologous
D000305:Adrenal Cortex Hormones; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents